Can Net Interest Income from 2010 to 2026

CANF Stock  USD 4.63  0.00  0.00%   
Can Fite's Net Interest Income is decreasing over the last several years with slightly volatile swings. Net Interest Income is estimated to finish at about 297 K this year. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2019-03-31
Previous Quarter
103 K
Current Value
113 K
Quarterly Volatility
163.9 K
 
Covid
 
Interest Hikes
Check Can Fite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Can Fite's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6 K, Interest Expense of 12 K or Total Revenue of 1.1 M, as well as many indicators such as Price To Sales Ratio of 55.2 K, Dividend Yield of 0.0 or PTB Ratio of 8.9 K. Can financial statements analysis is a perfect complement when working with Can Fite Valuation or Volatility modules.
  
Build AI portfolio with Can Stock
Check out the analysis of Can Fite Correlation against competitors.
The Net Interest Income trend for Can Fite Biopharma offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Can Fite is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Can Fite's Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of Can Fite Biopharma over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Can Fite's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Can Fite's overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Slightly volatile
   Net Interest Income   
       Timeline  

Can Net Interest Income Regression Statistics

Arithmetic Mean808,012
Geometric Mean498,325
Coefficient Of Variation109.48
Mean Deviation813,860
Median726,000
Standard Deviation884,590
Sample Variance782.5B
Range2.3M
R-Value(0.72)
Mean Square Error404.7B
R-Squared0.52
Significance0
Slope(125,734)
Total Sum of Squares12.5T

Can Net Interest Income History

2026297 K
2025249.3 K
2024277 K
2023726 K
2022-77 K
2021 2000.0
2020-342 K

About Can Fite Financial Statements

Can Fite stakeholders use historical fundamental indicators, such as Can Fite's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Can Fite investors may analyze each financial statement separately, they are all interrelated. For example, changes in Can Fite's assets and liabilities are reflected in the revenues and expenses on Can Fite's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Can Fite Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income249.3 K297 K

Currently Active Assets on Macroaxis

When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
Check out the analysis of Can Fite Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Can Biotechnology industry sustain growth momentum? Does Can have expansion opportunities? Factors like these will boost the valuation of Can Fite. Projected growth potential of Can fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Can Fite demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.82)
Return On Equity
(2.64)
Understanding Can Fite Biopharma requires distinguishing between market price and book value, where the latter reflects Can's accounting equity. The concept of intrinsic value - what Can Fite's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Can Fite's price substantially above or below its fundamental value.
It's important to distinguish between Can Fite's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Can Fite should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Can Fite's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.